Sun Pharmaceutical included in S&P Global Sustainability Yearbook 2025

17 Feb 2025 Evaluate

Sun Pharmaceutical Industries has been included in the S&P Global Sustainability Yearbook 2025. Sun Pharma has qualified in the Top 5% of pharmaceutical companies assessed by S&P globally for this Yearbook.

Within respective industries, this Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability. This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses. 

Based on the S&P Global Corporate Sustainability Assessment (CSA) for 2024, over 7,690 companies globally were assessed for The Sustainability Yearbook 2025. Out of these, 780 companies have qualified for inclusion in The Sustainability Yearbook 2025 globally.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1805.00 -13.60 (-0.75%)
05-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×